Abstract:
A manufacturing method of a tube type porous scaffold of a double-film structure for artificial blood vessel is provided to have excellent interconnectivity between air bubbles, mechanical stability, transfection and breeding efficiency and to prevent fistula blood at the hypertension state. A manufacturing method of a tube type porous scaffold of a double-film structure for artificial blood vessel comprises steps of: dissolving biodegradable polymer in organic solvent and mixing porogen and manufacturing a polymer/porogen mixed solution; coating a cylindrical shaft with polymer/porogen mixed solution and forming an inner film of a porous coating layer; dissolving the biodegradable polymer in the organic solvent and manufacturing a biodegradable polymer gel; dipping the cylindrical shaft forming the inner film of the porous coating layer, rotating it, falling and radiating the biodegradable polymer gel, winding fiber of a gel state to the inner film of the porous coating layer and forming an outer film of a polymeric fiber layer; separating porosity scaffold of the double-film structure formed in a shaft and removing the organic solvent and the porogen.
Abstract:
A solid acid catalyst for decomposing methanol and a method for producing the same are provided to suppress the generation of by products and prevent the reduction of hydrogen due to a methanation reaction between hydrogen and carbon monoxide. A solid acid catalyst is produced by hardening a mixture in which one or more kinds of solid acid are mixed. The solid acid is selected from kaolinite, bentonite, attapulgite, zeolite, montmorillonite, ZnO, Al2O3, TiO2, CeO2, V2O5, SiO2, Cr2O3, CaSO4, MnSO4, NiSO4, CuSO4, CoSO4, CdSO4, MgSO4, FeSO4, Al2(SO4)3, ZnSO4, Ca(NO3)2, Zn(NO3)2, Fe(NO3)3, AlPO4, FePO4, CrPO4, Cu3(PO4)2, Zn3(PO4)4, Mg3(PO4)2, AlCl3, TiCl4, CaCl2, AgCl, CaF2, and BaF2. Further, the solid acid is mixed with a sulphuric acid or a phosphoric acid, and plasticized.
Abstract:
Provided is a porous osteochondral composite scaffold with layer structure which has features of bioactivation and mechanical strength suitable to regenerate cartilage and bone simultaneously and method for manufacturing the same. The porous osteochondral composite scaffold comprises: a porous bone regeneration layer which includes biocompatable high molecule and bioactivation ceramic; a porous cartilage regeneration layer which includes biocompatable elastic high molocule. The method for manufacturing a porous osteochondral composite scaffold comprises the steps of: mixing biocompatable high molecule, bioactivation ceramic and lacuna-forming material; press-forming the mixed material from the first step in a mold; bonding the obtained material from the second step by heating to form a porous bone regeneration layer; forming composite material by press-forming gelled mixed material for forming cartilage which dissolves in solution with biocompatable high molecule and lacuna-forming material on one surface of the regenerated layer from the third step; removing solution and lacuna-forming material in the composite material from the fourth step.
Abstract:
A method of preparing porous polymer is provided to improve a cell seeding efficiency by a uniform size of a gap and excellent interconnectedness between gaps, and to prepare simply porous polymer scaffold appropriate for a tissue engineering by an excellent mechanical strength. The method comprises the steps of: manufacturing polymer solution by melting biocompatible polymers in organic solvents; forming polymer gel from non-solvent solutions by spinning the polymer solution obtained in the pre-step to non-solvent stirred by a rotating shaft; forming porous polymer scaffold by making the polymer gel formed in the pre-step wound on the rotating shaft; and removing the organic solvents by drying the porous polymer scaffold obtained in the pre-step.
Abstract:
본 발명은 술폰산화 폴리에틸렌옥시드(PEO, poly(ethylene oxide))를 함유하는 비닐 단량체와 그 중합체 및 그들의 제조 방법에 관한 것이다. 본 발명의 단량체로 이루어진 중합체 및 표면 그라프트 개질체는 항혈전성이 우수하므로 혈액과 접촉되는 의료용 소재로 응용할 수 있다. 술폰산화 PEO 함유 비닐 단량체, 항혈전성 중합체, 의료용 재료
Abstract:
본 발명은 뛰어난 유연성 및 적당한 가수분해성을 가진 생분해성 고분자 및 이 중합체로부터 형성된 다공성 지지체에 관한 것이다. 더욱 상세히 말하자면, 본 발명은 생분해성 재료인 락타이드와 ε-카프로락톤을 이용하여 중량 평균 분자량이 10,000 이상인 락타이드/ε-카프로락톤의 생분해성 공중합체를 제조하고, 이를 이용하여 상처피복재, 세포 배양용 지지체 재료로 사용 가능한 다공성 지지체 제조에 관한 것이다.
Abstract:
PURPOSE: Provided is a porous support obtained from biodegradable lactide/epsilon-caprolactone copolymer, which has excellent mechanical properties including flexibility and elasticity suitable to be used in tissue engineering. CONSTITUTION: The porous support obtained from biodegradable lactide/ epsilon-caprolactone copolymer has repeating units represented by formula 1 and a weight average molecular weight of 10,000 or more, wherein the mole ratio of lactide to epsilon-caprolactone is 2:8 to 8:2: wherein each of x and y is an integer of 1 or more, and n is an integer of 18 or more. Particularly, the porous support has a pore size of 1 to 800 micrometers and a porosity of 50-99%.
Abstract:
Disclosed is a biocompatible medical material and porous scaffold for use in tissue engineering, made from a biodegradable glycolide/epsilon-caprolactone copolymer having a repeat unit of wherein x and y are integers greater than or equal to 18, the copolymer has an average molecular weight of about 10,000 daltons or more, and the molar ratio of glycolide: epsilon-caprolactone in the copolymer is about 4.0:6.0 to 6.0:4.0.
Abstract:
PURPOSE: A porous substrate of a biodegradable polymer for regenerating an impaired ocular tissue is provided to cure the impaired ocular tissue by installing in the impaired ocular tissue region. CONSTITUTION: The porous substrate of the biodegradable polymer for regenerating the impaired ocular tissue is prepared with the biodegradable polymer selected from the group consisting of polyglycolic acid, polylactic acid, polycaprolactone, polydioxanone, polytrimethylene carbonate and copolymer thereof, and has the pore size of 10 to 800 micrometers, and the porosity of 50 to 99%. The ocular region is selected from the group consisting of cornea, conjunctiva and sclera.
Abstract:
PURPOSE: A poly-methyl methacrylate having hydrophilic surface and a use thereof as ophthalmic material are provided, which maintains an optical property of PMMA and which reduces adhesion growth of cell and protein. CONSTITUTION: A preparation method of poly-methyl methacrylate having hydrophilic surface is formed by bonding poly-ethylene oxide derivative of formula: NH2-R1-O-(CH2CH2O)n-X containing amino group at the end in the presence of catalyst at the surface of poly-methyl methacrylate chemically. In formula, R1 is (CH2CH2)2-3, n is 15-300, X is hydrogen, CH3, (CH2CH2)2-3-NH2 or (CH2CH2)2-3-NH-(CH2)3-SO3H. The molecular weight of poly-ethylene oxide is 200-10,000. The catalyst is tri-ethylamine.